[clinicaltrials_resource:383d4abbdd20936668a7228c0bdbbda7]
Adjuvant CCRT vs CT in Minimal N2 NSCLC [clinicaltrials:NCT01066234]Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer [clinicaltrials:NCT01079481]Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer [clinicaltrials:NCT01126008]Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer [clinicaltrials:NCT01130753]Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer [clinicaltrials:NCT01312324]Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) [clinicaltrials:NCT01312350]
responsible party [clinicaltrials_vocabulary:responsible-party]
[clinicaltrials_resource:383d4abbdd20936668a7228c0bdbbda7]
Bio2RDF identifier
383d4abbdd20936668a7228c0bdbbda7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:383d4abbdd20936668a7228c0bdbbda7
investigator affiliation [clinicaltrials_vocabulary:investigator-affiliation]
Samsung Medical Center
investigator full name [clinicaltrials_vocabulary:investigator-full-name]
Keunchil Park
investigator title [clinicaltrials_vocabulary:investigator-title]
Principal investigator
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:383d4abbdd20936668a7228c0bdbbda7
type
label
[clinicaltrials_resource:383d4abbdd20936668a7228c0bdbbda7]
@en